ImCare Biotech: Funding, Investors & Team (Oct 2026)
ImCare Biotech is a biotech firm focused on providing diagnostic and pharmaceutical products for treating cancers, viral infections, and other chronic diseases. The company is actively working on developing diagnostic biomarkers and drugs for liver diseases like hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Its main objective is to enhance the care provided to patients and their families by delivering top-notch commercial products through diligent research and innovation. ImCare Biotech, founded in 2011, is based in Doylestown, Pennsylvania.
ImCare Biotech has raised $550k across 2 funding rounds on record, the most recent a Seed of $150k announced in Jul 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ImCare Biotech Company Profile and Key Stats
Latest funding round on record: Jul 2023.
ImCare Biotech Funding Rounds
ImCare Biotech raised $400k in a Seed announced in Apr 2022.
1.3 years later, a Seed of $150k was announced in Jul 2023.
ImCare Biotech Founders and Leadership Team
No contact details are on record for this team yet.
ImCare Biotech Funding Compared to Other Biotechnology Startups
ImCare Biotech's latest round of $150k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ImCare Biotech in Biotechnology and Doylestown
Companies Similar to ImCare Biotech
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
ImCare Biotech Funding FAQs
What does ImCare Biotech do?
ImCare Biotech is a biotech firm focused on providing diagnostic and pharmaceutical products for treating cancers, viral infections, and other chronic diseases. The company is actively working on developing diagnostic biomarkers and drugs for liver diseases like hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Its main objective is to enhance the care provided to patients and their families by delivering top-notch commercial products through diligent research and innovation. ImCare Biotech, founded in 2011, is based in Doylestown, Pennsylvania.
How much funding has ImCare Biotech raised?
ImCare Biotech has raised $550k across 2 rounds on record. The most recent is a Seed of $150k announced in Jul 2023.
When did ImCare Biotech last raise funding?
ImCare Biotech's most recent funding round on record is a Seed of $150k, announced in Jul 2023.
Who founded ImCare Biotech?
FundedIQ lists Xuan Lu (Founder) at ImCare Biotech.
Who is the CEO of ImCare Biotech?
Aaron Yefei Lu is listed as CEO at ImCare Biotech.
Where is ImCare Biotech headquartered?
ImCare Biotech is based in Doylestown, Pennsylvania, United States.
How many employees does ImCare Biotech have?
ImCare Biotech is in the 1-10 employee band.
How does ImCare Biotech's funding compare to other Biotechnology startups?
ImCare Biotech's latest round of $150k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ImCare Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ImCare Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.